Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03331952 |
Date of registration:
|
01/11/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
A Study of Streptococcus Pneumonia Colonisation and Invasive Disease in Cambodian Children
PCV |
Scientific title:
|
Monitoring Pneumococcal Conjugate Vaccine Introduction in Cambodia: A Study of Streptococcus Pneumoniae Colonisation, Pneumonia and Invasive Disease in Cambodian Children |
Date of first enrolment:
|
August 3, 2015 |
Target sample size:
|
4111 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03331952 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Cambodia
| | | | | | | |
Key inclusion & exclusion criteria
|
Group1: PCV-D
Inclusion:
- Age: 0 - 59 months on the day of assessment / culture AND
- S.pneumoniae identified from a normally sterile site culture. OR
- WHO Coordinated Invasive Bacterial Vaccine Preventable Diseases (IB-VPD) Surveillance
Network Case Definition for probable bacterial meningitis. Clinically suspected
meningitis and a CSF examination with at least one of:
- Turbid appearance.
- Leucocytosis (WBC count of >100 cells/mm3).
- Leucocytosis (10-100 cells/mm3) AND either an elevated protein (>100 mg/dL) or
decreased glucose (<2.2 mmol/L).
Exclusion:
- Previous enrolment within the last 14 days.
- Parent / guardian or caretaker refused consent.
Group2: PCV-P
Inclusion:
- Age: 0 - 59 months on the day of admission AND
- Admission to the IPD, ER/ICU, or NICU/SCBU. AND
- Meets the WHO Coordinated Invasive Bacterial Vaccine Preventable Diseases (IB-VBD)
Surveillance Network pneumonia / severe pneumonia case definition:
- Cough and/or difficulty breathing. AND
- Tachypnoea OR
- Inability to breast feed or drink.
- Vomiting everything.
- Convulsions.
- Prostration/lethargy.
- Chest indrawing.
- Stridor when calm.
Exclusion:
- Previous enrolment within the last 14 days.
- Parent / guardian or caretaker refused consent.
Group3: PCV-C
Inclusion:
• Age: 0 - 59 months on the day of recruitment
Exclusion:
- Parent / guardian or caretaker reports symptoms of potential acute lower respiratory
tract illness.
- Triage nurse selects child for doctor review / hospital admission.
- Previous enrolment in the current annual survey.
- Parent / guardian or caretaker refused consent.
Age minimum:
N/A
Age maximum:
59 Months
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Streptococcal Pneumonia
|
Intervention(s)
|
Other: Cross-sectional surveys
|
Other: Prospective study
|
Primary Outcome(s)
|
Invasive pneumococcal disease hospitalisation rates
[Time Frame: 3 years]
|
Characteristics of invasive S. pneumoniae isolates in children <5 years of age admitted to Angkor Hospital for Children, in relation to national introduction of PCV13 in Cambodia
[Time Frame: 3 years]
|
Secondary Outcome(s)
|
Genotype in relation to national introduction of PCV13
[Time Frame: 3 years]
|
Pneumococcal colonisation prevalence
[Time Frame: 3 years]
|
Antimicrobial susceptibility profiles in relation to national introduction of PCV13
[Time Frame: 3 years]
|
Changes in pneumonia (both clinical and radiologic) hospitalisation rates in children <5 years of age, in relation to national introduction of PCV13 in Cambodia
[Time Frame: 3 years]
|
Serotype in relation to national introduction of PCV13
[Time Frame: 3 years]
|
Compare pneumococcal serotype colonisation in pneumonia cases with children attending the hospital out-patients for minor illnesses
[Time Frame: 3 years]
|
Secondary ID(s)
|
COMRU1501
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|